Aethlon Medical Inc (AEMD NASDAQ) stock market data APIs
$2.8759
0.03(1%)
as of December 22, 2025
Try our APIs with
free plan!
Aethlon Medical Inc Financial Data Overview
Price chart is built with
Anychart
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Prev. Close
2.8759
Open
2.904
High
2.9476
Low
2.8675
52 wk Range
2.83-84.4
Market Cap
2 193 K
P/E Ratio
0.0137
Shares Outstanding
761 K
Revenue
574 K
EPS
-3.74
Beta
1.641
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aethlon Medical Inc data using free add-ons & libraries
Get Aethlon Medical Inc Fundamental Data
Aethlon Medical Inc Fundamental data includes:
- Net Revenue: 574 K
- EBITDA: -6 758 249
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -1.08
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aethlon Medical Inc News
New
Aethlon Medical signals expanded Australian oncology enrollment strategy while operating loss narrows to $1.5M
Earnings Call Insights: Aethlon Medical (AEMD) Q2 2026 MANAGEMENT VIEW * CEO James Frakes opened the call highlighting progress on the Australian oncology trial and ongoing alignment of resources ...
Aethlon Medical Prices $4.5 Mln Public Offering Of Common Stock And Warrants
(RTTNews) - Aethlon Medical, Inc. (AEMD), a company developing therapies for cancer and infectious diseases, has priced a public offering of 5,000,000 shares of common stock or pre-funded warrants and...
Let's take a look at the stocks that are in motion in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TOP GAINERS TICKER CHANGE COMMENT CIGL [https://www.chartmill.com/s...
Aethlon Medical Prices $4.5 Mln Public Offering Of Common Stock And Warrants
(RTTNews) - Aethlon Medical, Inc. (AEMD), a therapeutic company developing treatments for cancer and infectious diseases, has priced a public offering of 5 million common shares and accompanying warra...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
